Association of Admission Blood Pressure with Outcome in Cerebral Hemorrhage

doi:10.3969/j.issn.1673-5765.2022.07.016

Abstract

Abstract:

Objective To explore the relationship between admission blood pressure (BP) and outcomes in patients with cerebral hemorrhage.

Methods This study collected the data of patients with spontaneous intracerebral hemorrhage from the China National Stroke Registry Ⅱ (CNSRⅡ) database. Logistic regression model was used to analyze the relationship between systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and the outcomes (including in-hospital death, 3-month death, 3-month poor prognosis and 1-year poor prognosis), after adjusting for the confounding factors.

Results A total of 1048 patients were included in this study, with an average age of 62.1±12.5 years and 666 males (63.5%). At admission, the average SBP was 162.1±28.9 mmHg, the average DBP was 95.1±17.6 mmHg, and the average MAP was 117.4±20.1 mmHg. Compared with patients with SBP 120-139 mmHg at admission, the patients with SBP 180-199 mmHg (OR 17.53, 95%CI 2.25-136.66, P=0.0063) and SBP ≥200 mmHg (OR 21.74, 95%CI 2.74-172.55, P=0.0036) had a higher in-hospital mortality rate. The risk of in-hospital mortality (OR 1.25, 95%CI 1.14-1.37, P<0.0001), 3-month poor prognosis (OR 1.08, 95%CI 1.02-1.15, P=0.0066), and 3-month mortality (OR 1.13, 95%CI 1.04-1.22, P=0.0049) all increased per an increase of 10 mmHg in admission SBP. The risk of in-hospital mortality (OR 1.36, 95%CI 1.16-1.59, P=0.0001), 3-month poor prognosis (OR 1.16, 95%CI 1.05-1.29, P=0.0034), and 3-month mortality (OR 1.20, 95%CI 1.05-1.38, P=0.0093) all increased per an increase of 10 mmHg in admission DBP. The risk of in-hospital mortality (OR 1.37, 95%CI 1.20-1.57, P<0.0001), 3-month poor prognosis (OR 1.13, 95%CI 1.04-1.23, P=0.0044), and 3-month mortality (OR 1.20, 95%CI 1.06-1.35, P=0.0036) all increased per an increase of 10 mmHg in admission MAP.

Conclusions Admission SBP, DBP and MAP levels were independent risk factors for in-hospital death and 3-month poor prognosis in patients with intracerebral hemorrhage, but were not associated with 1-year poor prognosis.

Key words: Cerebral hemorrhage; Cerebrovascular disease; Blood pressure; Outcome; Death; Risk factor

摘要：

目的通过中国国家卒中登记Ⅱ（China national stroke registry Ⅱ，CNSRⅡ）的数据，分析入院收缩压（systolic blood pressure，SBP）、舒张压（diastolic blood pressure，DBP）及平均动脉压（mean arterial pressure，MAP）与脑出血患者死亡和功能结局的关系。

方法收集CNSRⅡ数据库中自发性脑出血患者的人口学信息和临床数据，应用logistic回归分析患者入院时不同SBP分层、SBP、DBP和MAP对患者短期和长期预后（包括院内死亡、3个月死亡及预后不良和1年预后不良）的影响。

结果共有1048例脑出血患者的资料纳入统计分析，平均年龄62.1±12.5岁，男性666例（63.5%）。入院时平均SBP为162.1±28.9 mmHg，平均DBP为95.1±17.6 mmHg，平均MAP为117.4±20.1 mmHg。与入院SBP 120～139 mmHg的患者相比，入院SBP 180～199 mmHg（OR 17.53，95%CI 2.25～136.66，P=0.0063）和SBP≥200 mmHg的患者（OR 21.74，95%CI 2.74～172.55，P=0.0036）的在院死亡风险均增加。入院SBP每升高10 mmHg，患者在院死亡风险（OR 1.25，95%CI 1.14～1.37，P<0.0001）、3个月预后不良（OR 1.08，95%CI 1.02～1.15，P=0.0066）和死亡风险（OR 1.13，95%CI 1.04～1.22，P=0.0049）均增加。入院DBP每升高10 mmHg，患者在院死亡风险（OR 1.36，95%CI 1.16～1.59，P=0.0001）、3个月预后不良（OR 1.16，95%CI 1.05～1.29，P=0.0034）和死亡风险（OR 1.20，95%CI 1.05～1.38，P=0.0093）均增加。入院MAP每升高10 mmHg，患者在院死亡风险（OR 1.37，95%CI 1.20～1.57，P<0.0001）、3个月预后不良（OR 1.13，95%CI 1.04～1.23，P=0.0044）和死亡风险（OR 1.20，95%CI 1.06～1.35，P=0.0036）均增加。

结论入院SBP、DBP和MAP水平是脑出血患者院内死亡和3个月预后不良的独立危险因素，但对患者1年预后不良无独立影响。

关键词: 脑出血; 脑血管病; 血压; 预后; 死亡; 危险因素

SONG Xinjie, JIANG Ruixuan, ZHANG Yijun, WANG Anxin, LI Zixiao, ZHAO Xingquan. Association of Admission Blood Pressure with Outcome in Cerebral Hemorrhage[J]. Chinese Journal of Stroke, 2022, 17(07): 769-773.

宋新杰, 姜睿璇, 张怡君, 王安心, 李子孝, 赵性泉. 脑出血急性期不同血压参数与预后的关系[J]. 中国卒中杂志, 2022, 17(07): 769-773.

References

[1] LEONARDI-BEE J，BATH P M W，PHILLIPS S J，et al. Blood pressure and clinical outcomes in the international stroke trial[J]. Stroke，2002，33（5）：1315-1320.

[2] FOGELHOLM R，AVIKAINEN S，MURROS K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage[J]. Stroke，1997，28（7）：1396-1400.

[3] AIYAGARI V，GORELICK P B. Management of blood pressure for acute and recurrent stroke[J]. Stroke，2009，40（6）：2251-2256.

[4] FRANCOEUR C L，MAYER S A，VISTA-ICH Collaborators. Acute blood pressure and outcome after intracerebral hemorrhage：the VISTA-ICH cohort[J/OL]. J Stroke Cerebrovasc Dis，2021，30（1）：105456[2021-12-28]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105456.

[5] QURESHI A I，HUANG W，LOBANOVA I，et al. Outcomes of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage and excessively high initial systolic blood pressure：post hoc analysis of a randomized clinical trial[J]. JAMA Neurol，2020，77（11）：1355-1365.

[6] WANG Y J，CUI L Y，DONG Q，et al. The China national stroke registry for patients with acute cerebrovascular events：design，rationale，and baseline patient characteristics[J]. Int J Stroke，2011，6（4）：355-361.

[7] ENOS Trial Investigators. Efficacy of nitric oxide，with or without continuing antihypertensive treatment，for management of high blood pressure in acute stroke（ENOS）：a partial-factorial randomised controlled trial[J]. Lancet，2015，385（9968）：617-628.

[8] ROTHWELL P M. Limitations of the usual blood-pressure hypothesis and importance of variability，instability，and episodic hypertension[J]. Lancet，2010，375（9718）：938-948.

[9] OKUMURA K，OHYA Y，MAEHARA A，et al. Effects of blood pressure levels on case fatality after acute stroke[J]. J Hypertens，2005，23（6）：1217-1223.

[10] KERR D M，FULTON R L，HIGGINS P，et al. Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke：evidence from the virtual international stroke trials archive[J]. Stroke，2012，43（2）：399-404.

[11] CHANG J J，KHORCHID Y，DILLARD K，et al. Elevated pulse pressure levels are associated with increased in-hospital mortality in acute spontaneous intracerebral hemorrhage[J]. Am J Hypertens，2017，30（7）：719-727.

[12] ARIMA H，HEELEY E，DELCOURT C，et al. Optimal achieved blood pressure in acute intracerebral hemorrhage：INTERACT2[J]. Neurology，2015，84（5）：464-471.

[1]	FENG Yuting, LIU Zhihan, CHAI Qianyun, LUO Minjing, GAO Yicheng, TAO Liyuan, FEI Yutong. Control of Confounders and Covariates in Real-World Studies: Cerebrovascular Diseasebased Cases Explanation [J]. Chinese Journal of Stroke, 2022, 17(12): 1304-1309.
[2]	JIN Aoming, PAN Yuesong. Application of Propensity Score in Clinical Research on Cerebrovascular Disease [J]. Chinese Journal of Stroke, 2022, 17(12): 1310-1313.
[3]	SONG Yanli, LIN Jie, WU Yiping, LI Xiaojing, LIU Gaifen, XIA Wenjing, ZHANG Yuying, ZHANG Xiaolin, LYU Chenran, ZHOU Hong, LI Kai, XUE Bin, CHEN Lingling, ZHANG Zhongbo, PENG Xiao. Epidemiological Survey on the Risk Factors of Cardio-Cerebrovascular Diseases among Residents in Handan and Influencing Factors of Awareness, Treatment and Control Rate of Hypertension [J]. Chinese Journal of Stroke, 2022, 17(12): 1360-1365.
[4]	YANG Hongna, JI Ruijun, YU Kai, HE Yan, XU Lihua, WANG Yongjun. Drug Adherence and Influencing Factors in Secondary Prevention of Ischemic Cerebrovascular Disease [J]. Chinese Journal of Stroke, 2022, 17(11): 1227-1232.
[5]	XU Zhichao, LI Runzhi, MI Donghua. Relationship between Central Insulin Resistance and Cerebrovascular Disease [J]. Chinese Journal of Stroke, 2022, 17(11): 1276-1282.
[6]	FU Jianghong, CHEN Shugeng, SHU Xiaokang, JIANG Zewu, WEI Dongshuai, JIA Jie. Effects of Brain-Computer Interface Training on Motor Function Recovery in Patients with Post-Stroke Sensory Impairment: An Exploratory Study [J]. Chinese Journal of Stroke, 2022, 17(10): 1051-1057.
[7]	XIAO Ruizhu, LI Lei, WANG Meng, JIANG Yong, GUO Jingpeng, ZHU Haogang. The Application of Blockchain-Based Digital Identity in Clinical Data Management of Cerebrovascular Diseases [J]. Chinese Journal of Stroke, 2022, 17(10): 1089-1096.
[8]	DONG Yi, ZHANG Yanrong, CAO Wenjie, CHENG Xin, DONG Qiang, GU Yuxiang. The Concept and Framework of Syncretic Stroke Unit [J]. Chinese Journal of Stroke, 2022, 17(10): 1139-1143.
[9]	LYU Wei, WANG Anxin, TIAN Xue, ZHANG Xiaoli, XU Yuyuan, MENG Xia. Effect of Xinxuening Capsule on Short-term Functional Outcome in Patients with Ischemic Stroke and High Homocysteine Level [J]. Chinese Journal of Stroke, 2022, 17(09): 972-976.
[10]	CHEN Yu, WANG Di, LI Guanzhang, ZHAO Zheng, LI Yiying. A Standardized Scheme of Collection, Storage and Transportation of Whole Blood Samples of Cerebrovascular Disease [J]. Chinese Journal of Stroke, 2022, 17(08): 911-914.
[11]	LI Jiashu, FANG Ruile, LIU Gaifen, ZHAO Xingquan, JU Yi. Clinical Features and Risk Factors of Persistent Vestibular Symptoms Associated with Acute Mild Stroke [J]. Chinese Journal of Stroke, 2022, 17(07): 780-785.
[12]	LU Jiajie, ZHAO Hongru. Headache Phenotypes and Possible Mechanisms of Dural Arteriovenous Fistula [J]. Chinese Journal of Stroke, 2022, 17(05): 461-465.
[13]	ZHANG Tong, WANG Anxin, AN Yuan, ZHANG Yaqing, LIU Yanfang, ZHAO Xingquan. Meta-analysis of Clinical Outcomes of Treatment for Anterior Circulation Tandem Lesions [J]. Chinese Journal of Stroke, 2022, 17(05): 503-509.
[14]	MO Dongcan, LIU Liuyu, LI Xiaoling, LI Jianli, LUO Man. Application of Zebrafish Model Organism in Stroke Research [J]. Chinese Journal of Stroke, 2022, 17(05): 548-552.
[15]	XU Zhe, CHENG Si, LIU Yang, SHI Yanfeng, LI Hao. Construction of Bioinformatics Pipeline for Genomics Data in Cerebral Vascular Disease Researches [J]. Chinese Journal of Stroke, 2022, 17(03): 217-226.